医療診断におけるAIの市場規模は、2023年に21億ドルと評価されました。この市場は、2024年の29億ドルから2032年までに292億ドルに成長し、予測期間(2024年から2032年)の間に39.00%のCAGRを示すと予測されます。医療診断におけるAlの使用は、Alベースの技術の使用を支援する政府のイニシアチブの増加、作業負荷を軽減するためにAlソリューションを採用する放射線科医の増加、ビッグデータの導入、Alベースのスタートアップへの資金提供の利用可能性、業界を超えたパートナーシップやコラボレーションの増加など、多くの市場促進要因により急速に拡大しています。
目次
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT
6.1. Overview
6.2. Software
6.3. Hardware
6.4. Services
7. GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION
7.1. Overview
7.2. In Vivo Diagnostics
7.3. In Vitro Diagnostics
8. GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER
8.1. Overview
8.2. Hospitals
8.3. Diagnostic Imaging Centers
8.4. Diagnostic Laboratories
8.5. Others
9. GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET, BY REGION
9.1. Overview
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. UK
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Middle East
9.4.2. Africa
9.4.3. Latin America
10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global AI in Medical Diagnostics Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global AI in Medical Diagnostics Market,
10.7. Key Developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2023
10.8.2. Major Players R&D Expenditure. 2023
11. COMPANY PROFILES
11.1. Siemens Healthineers
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Vuno, Inc.
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Nanox Imaging LTD (Zebra Medical Vision, Inc.)
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Riverain Technologies
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Aidoc
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. AliveCor Inc.
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Neural Analytics
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Digital Diagnostics, Inc.
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Imagen Technologies
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. GE Healthcare
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Products Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
11.11. Enlitic
11.11.1. Company Overview
11.11.2. Financial Overview
11.11.3. Products Offered
11.11.4. Key Developments
11.11.5. SWOT Analysis
11.11.6. Key Strategies
11.12. InformAI
11.12.1. Company Overview
11.12.2. Financial Overview
11.12.3. Products Offered
11.12.4. Key Developments
11.12.5. SWOT Analysis
11.12.6. Key Strategies
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 5 GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 9 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
TABLE 10 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 11 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 12 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
TABLE 13 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 14 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 1 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
TABLE 2 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 3 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 4 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
TABLE 5 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 6 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 7 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
TABLE 8 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 9 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 10 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
TABLE 11 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 12 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 13 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
TABLE 14 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 15 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 16 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
TABLE 17 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 18 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 19 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
TABLE 20 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 21 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 22 ASIA-PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
TABLE 23 ASIA-PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 24 ASIA-PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 25 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
TABLE 26 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 27 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 28 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
TABLE 29 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 30 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 31 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
TABLE 32 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 33 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 34 AUSTRALIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
TABLE 35 AUSTRALIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 36 AUSTRALIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 37 SOUTH KOREA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
TABLE 38 SOUTH KOREA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 39 SOUTH KOREA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 40 REST OF ASIA-PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
TABLE 41 REST OF ASIA-PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 42 REST OF ASIA-PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 43 REST OF THE WORLD: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
TABLE 44 REST OF THE WORLD: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 45 REST OF THE WORLD: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 46 MIDDLE EAST: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
TABLE 47 MIDDLE EAST: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 48 MIDDLE EAST: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 49 AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
TABLE 50 AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 51 AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 52 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2019-2032 (USD BILLION)
TABLE 53 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 54 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2019-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET
FIGURE 4 GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET, SHARE (%), BY COMPONENT, 2023
FIGURE 5 GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET, SHARE (%), BY APPLICATION, 2023
FIGURE 6 GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET, SHARE (%), BY END USER, 2023
FIGURE 7 GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2023
FIGURE 8 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 ASIA-PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 REST OF THE WORLD: AI IN MEDICAL DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2023
FIGURE 12 GLOBAL AI IN MEDICAL DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 13 SIEMENS HEALTHINEERS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 SIEMENS HEALTHINEERS: SWOT ANALYSIS
FIGURE 15 VUNO, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 VUNO, INC.: SWOT ANALYSIS
FIGURE 17 NANOX IMAGING LTD (ZEBRA MEDICAL VISION, INC.): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 NANOX IMAGING LTD (ZEBRA MEDICAL VISION, INC.): SWOT ANALYSIS
FIGURE 19 RIVERAIN TECHNOLOGIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 RIVERAIN TECHNOLOGIES: SWOT ANALYSIS
FIGURE 21 AIDOC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 AIDOC: SWOT ANALYSIS
FIGURE 23 ALIVECOR INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 ALIVECOR INC.: SWOT ANALYSIS
FIGURE 25 NEURAL ANALYTICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 NEURAL ANALYTICS: SWOT ANALYSIS
FIGURE 27 DIGITAL DIAGNOSTICS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 DIGITAL DIAGNOSTICS, INC.: SWOT ANALYSIS
FIGURE 29 IMAGEN TECHNOLOGIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 IMAGEN TECHNOLOGIES: SWOT ANALYSIS
FIGURE 31 GE HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 GE HEALTHCARE: SWOT ANALYSIS
FIGURE 33 ENLITIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 ENLITIC: SWOT ANALYSIS
FIGURE 35 INFORMAI: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 INFORMAI: SWOT ANALYSIS
